Skip to main content

Seroprevalence of Toscana virus in blood donors in mainland Portugal

Abstract

Background

Toscana virus (TOSV; Phlebovirus toscanaense), a phlebovirus transmitted by sand flies, is a growing public health concern in the Mediterranean region, with infections often being asymptomatic but potentially leading to neuroinvasive disease. Despite its presence in neighboring countries, data on TOSV seroprevalence in Portugal are limited. This study aimed to estimate the national seroprevalence of TOSV among blood donors in mainland Portugal and explore associations with sociodemographic factors and Leishmania infection.

Methods

A cross-sectional study was conducted using serum samples from 3593 blood donors across mainland Portugal, collected between February and June 2022. Anti-TOSV antibodies were detected via microneutralization assay, and anti-Leishmania antibodies had previously been tested using ELISA. Sociodemographic data were obtained from self-administered questionnaires. Seroprevalence was estimated by region, and multivariate logistic regression was used to identify factors associated with TOSV infection.

Results

Overall, the estimated national true seroprevalence of TOSV was 2.6% (95% CI 2.1–3.1%). Regional seroprevalence varied significantly, with the highest values (up to 14.8%) in Alto Alentejo, Baixo Alentejo, Douro, Alto Tâmega e Barroso and Oeste regions. Multivariate analysis showed that age ≥ 50 years (aOR 1.70, 95% CI 1.04–2.77), residing in the Alentejo region (aOR 3.05, 95% CI 1.85–5.02) and positive/borderline Leishmania serology (aOR 2.31, 95% CI 1.29–4.15) were significantly associated with TOSV infection.

Conclusions

This study highlights new areas of TOSV circulation in Portugal, particularly in regions with higher Leishmania seroprevalence and visceral leishmaniasis incidence, suggesting co-circulation of these pathogens. Although a lower seroprevalence was obtained compared to neighboring countries, TOSV should still be considered in the differential diagnosis of viral meningitis and encephalitis in Portugal, especially in potentially high-risk regions. Further research is needed to better understand the ecological drivers of TOSV distribution in Portugal.

Graphical Abstract

Background

The Phlebovirus genus, belonging to the Phenuiviridae family, includes 68 species [according to the latest classification of the International Committee on Taxonomy of Viruses [1], some of which are pathogenic to humans. These viruses are transmitted by arthropod vectors, including phlebotomine sand flies, ticks [2] and mosquitoes (e.g. Rift Valley fever virus, RVFV [3]). Species of this genus that are transmitted by sand flies have been particularly neglected in terms of professional and public awareness, research funding, surveillance and public health prioritization, owing, in part, to their typically mild or asymptomatic clinical presentation. However, they represent a potential threat to human and animal health as there is increasing potential for their geographic expansion in the context of climate change and globalization.

Phleboviruses transmitted by sand flies in the Old World with well-known pathogenic potential (in humans) are currently grouped into three species, all of which are circulating in the Mediterranean region: Naples virus (Phlebovirus napoliense), Sicilian virus (Phlebovirus siciliaense) and Toscana virus (TOSV; Phlebovirus toscanaense) [4]. Infection by these viruses can result in a broad clinical spectrum, although asymptomatic infection seems to be the most common outcome (only detectable through seropositivity) [5]. In symptomatic individuals, the most frequent presentation, known as sandfly fever or Pappataci fever, usually manifests as a nonspecific, self-limited febrile syndrome (with an average duration of 3 days), often characterized by headaches, muscle pain and nausea/vomiting [6]. However, TOSV is neurotropic, and infection of the central nervous system (CNS) can result in meningitis, encephalitis and other less common forms of involvement (such as peripheral neuropathy and Guillain-Barré syndrome). Fatal cases or those with permanent sequelae are rare [7].

Advancement in the understanding of the epidemiology of TOSV has primarily been realized through molecular biology and/or serological studies in cerebrospinal fluid (CSF) and serum from patients with suspected acute CNS infection (prospectively and retrospectively). The percentage of CNS infections attributed to TOSV in these studies was variable: 4.6–6.5% in Italy [8, 9] (although this percentage reached 81.0% in specific regions and years during the summer [10]), 10.0% in Tunisia [11] and 1.0% in Portugal [12]. Sporadic cases of TOSV CNS infection acquired in Portugal have also been documented previously, including in foreign tourists in 1985 [13] and in 1996 [14] and in Portuguese inhabitants (a total of 11 cases, diagnosed between 2002 and 2008, reported in two studies [15, 16]). Additionally, the recent identification of neuroinvasive disease caused by TOSV in individuals (without travel history) from areas previously considered non-endemic, such as southwest Germany, is noteworthy [17].

In addition, serological cross-sectional studies of human and animal populations in confirmed or potentially endemic areas have also significantly contributed to epidemiological knowledge. Some of these studies have targeted blood donors in the Mediterranean Basin, showing TOSV seroprevalences ranging from 0 to 26% in France, Italy and Spain [18,19,20,21,22]. In Portugal, three seroprevalence studies on TOSV in healthy individuals showed values of 1.1–5.3% in the Porto [23], Lisbon, Santarém [20] and Setúbal districts [24, 25]. Additionally, in Portugal, recent seroprevalence rates of 3.7–6.8% for TOSV were detected in dogs and cats in various regions [26,27,28]. In wild animals, exposure to TOSV has been detected in foxes and wolves but not in rodents [29].

Phlebotomus perniciosus has been identified as the main vector of TOSV [30]. This species seems to be widespread in Portugal, according to data from national sand fly surveillances, gradually implemented since 2016 [31]. Phlebotomus perniciosus has also been recognized as the main vector of Leishmania infantum in the western Mediterranean [32], and cocirculation of the two pathogens has been suggested by the detection in sand flies collected in the same endemic areas, including in Portugal [33], and statistical association in seroprevalence studies in humans [34]. Other sand fly species have been detected in Portugal (Phlebotomus ariasi, P. papatasi, P. sergenti and Sergentomyia minuta) but seem to have a more localized distribution in the country [31].

In this context, this study aimed to estimate the national seroprevalence of TOSV in blood donors in mainland Portugal through the detection of antibodies using the microneutralization technique and to study the association between the presence of anti-TOSV antibodies and anti-Leishmania antibodies as well as various sociodemographic factors in this population and the practices of individuals regarding daily activities and pet ownership.

Methods

Study population

Data and samples for this work had previously been collected for another cross-sectional Leishmania seroprevalence study [35]. A detailed description of the study methodology can be found in [35], and a summary is provided in Supplementary Table S1. That study targeted the population of people who donate blood in mainland Portugal through the Portuguese Institute of Blood and Transplantation (IPST) or the immunohemotherapy departments (IHDs) of public hospitals in the Alentejo and Algarve regions. The IPST and the IHDs perform regular blood collections in fixed centers as well as collections in shifting stations in rural and urban areas. In 2021, over 190,000 blood donations were performed in these institutions [36, 37], after a strict and standardized triage process. Mainland Portugal is located in Southwest Europe, bordering Spain and the Atlantic Ocean, and is divided into seven NUTS2 regions, 24 NUTS3 regions [37], 278 municipalities and 2882 parishes. According to the 2021 national census, the population of mainland Portugal aged 15–64 years old was 6,257,752 inhabitants [38].

Data and sample collection

The sampling was stratified by municipality. The individuals enrolled in the original study presented to one of the institutions collaborating in the study from February to June 2022 and were considered fit for blood donation. Only individuals aged 18–65 years old were included. Participant enrollment was performed in non-randomly selected blood collection sessions, but, in each session, invitation to participate in the study was random (by time of presentation at the blood collection center/station). Each participant filled in a self-administered structured paper questionnaire about sociodemographic aspects; 1.5 ml of the routinely collected serum was sent to the Instituto de Higiene e Medicina Tropical (IHMT) and stored at – 20 ºC for the study. Only participants who consented to be included in further studies were included in the TOSV seroprevalence study.

Categorical variables extracted from the questionnaire were analyzed mostly using the original categories provided as answer options, but regrouping was performed in some cases. Classification of professions was performed using the ESCO Classification of Occupations, developed by The European Commission in 2010 [39]. Classification of parishes as rural or non-rural followed the Portuguese Rural Development Program 2014–2020 [40]. TOSV endemic travel destinations included countries where human or animal infection/disease has been reported, according to [7].

Serological study

Anti-TOSV antibodies were detected by microneutralization technique. Human sera were heat-inactivated at 56 °C for 30 min, then diluted from 1:10 to 1:80 and mixed in equal volumes with 1000 TCID₅₀ of TOSV (MRS2014–44725) in 96-well plates. Following a 1-h incubation at 37 °C, 100 μl of a Vero E6 cell suspension (5 × 105 cells/ml) was added. Each plate included positive and negative controls. After 5 days, cytopathic effect (CPE) was assessed, and neutralization titers were determined by TCID50. Detection of antibodies in any titer was considered a positive result. A sensitivity of 98.1% and specificity of 98.8% were assumed for this technique; these were calculated for CPE-based VNT with reference to PRNT90 for Zika virus [41] since data for TOSV are not available, but the same technique was used.

Antileishmanial antibody detection in each serum sample had already been performed using ELISA (Leishmania ELISA IgG + IgM, Vircell®, Spain), following the manufacturer’s instructions and cut-offs. These kits simultaneously detect IgM and/or IgG antibodies against Leishmania; the plate’s wells are coated with an unspecified L. infantum antigen. The sensitivity and specificity of the ELISA, according to the manufacturer, are 97% and 99%, respectively. A single determination was performed for each serum sample. Samples were classified as positive, negative or borderline (when optical density was < 10% lower or higher than the average value of the borderline controls).

Statistical analysis

True prevalence was estimated at national and regional level based on the following formula: true prevalence (TP) = (test prevalence—1 + specificity)/(sensitivity—1 + specificity). The corresponding 95% CIs were obtained using the Wilson’s method on Epitools© Epidemiological Calculators [42, 43].

Absolute and relative frequencies and hypothesis testing were performed using IBM® SPSS® Statistics Version 29.0. Geographical representation and analysis of results were obtained using QGIS® Version 3.22. Descriptive statistics were expressed as absolute frequencies and percentages for categorical variables and as medians with interquartile intervals (IQIs) for asymmetric continuous variables (e.g. age). Missing or unknown data were excluded from denominators, unless stated otherwise. Comparisons between groups were performed using Pearson Chi-square test for categorical variables (or Fisher’s exact in case of failure of the assumptions of the χ2 test). A value of p < 0.05 was considered statistically significant.

Multivariate analysis was conducted to identify sociodemographic factors associated with TOSV infection. This analysis was performed through a multiple binary logistic regression model, analyzing variables with statistical meaning in the univariate analysis (p < 0.20) and some biologically relevant or potentially confounding variables.

For those variables that remained significant, crude odds ratio (OR) were updated to adjusted odds ratio (aOR) with 95% CI. The Hosmer-Lemeshow test was used for assessing goodness of fit in each multiple logistic regression model [44]. The reference categories used for each independent variable are specified in each multivariate analysis results table.

Results

In total, 3593 participants were included in this study. Participants were recruited in 636 blood collection sessions in 347 different collection sites. Globally, 235 of the 278 municipalities of mainland Portugal were represented. Missing municipalities were concentrated in the eastern Algarve, Alto Alentejo, Coimbra and Alto Minho NUTS3 regions. Median age was 41 years old, and it was higher in Península de Setúbal, Alentejo and Algarve NUTS2 regions (Table 1). Participants were evenly distributed between sexes globally and in most regions, except for the Alentejo and the Algarve, where male sex was clearly predominant. Differences in education level, occupation, contact with domestic animals, ownership of dogs and practice of outdoor activities during nighttime between NUTS2 regions were noted and are presented in Table 1.

Table 1 Sociodemographic characteristics of the participants, globally and by NUTS (Nomenclature of Territorial Units for Statistics) 2 region

Serological results

In total, 142 (4.0%) samples were positive for TOSV antibodies. Distribution of positive results by NUTS2 and three regions is given in Table 2. Adjusted positivity rates were considered slight deviations between the expected and the achieved sample size by municipality. Figure 1 shows the distribution of true seroprevalence estimates by NUTS3 region.

Table 2 Distribution of positive results by NUTS (Nomenclature of Territorial Units for Statistics) 2 and 3 region and estimated true prevalence
Fig. 1
figure 1

Distribution of estimated TOSV true seroprevalence values (%) by NUTS3 region

Global estimated true seroprevalence was 2.6% (95% CI 2.1–3.1%). At the NUTS3 level, values ranged from 0.0 to 14.8%, with highest seroprevalences in the Alto Alentejo, Douro and Baixo Alentejo regions. There was a statistically significant difference in the proportion of positive results between NUTS2 regions (p < 0.001, Chi-square test, χ2 = 33.2, df = 6).

To allow a more detailed analysis of the geographical distribution of possible exposure to TOSV, the percentage of positive samples was calculated by municipality and is given in Fig. 2. Municipalities where at least 15 samples were collected (n = 73) with the highest percentages (> 9.0%) were (by descending order): Alenquer, Moita, Serpa, Alcobaça, Seixal and Caldas da Rainha. Additionally, to understand possible clustering of positive cases at a more local level, percentage by parish is illustrated for the Grande Lisboa and Península de Setúbal NUTS3 regions in Fig. 3.

Fig. 2
figure 2

Percentage of TOSV-positive samples by municipality (natural breaks were used to define categories; the approximate location of district capital cities is highlighted)

Fig. 3
figure 3

Percentage of positive samples in each parish of the Grande Lisboa and Península de Setúbal regions

Associations between sociodemographic variables and asymptomatic infection

In univariate analysis, residing in the Alentejo region (considering the Centro as a reference category), age > 44 years old and basic level of education were significantly associated with a positive serological result (Table 3). People with a positive result more often reported regular practice of outdoor activities during nighttime (p = 0.056, Chi-square test, χ2 = 3.6, df = 1) and more often had a positive or borderline Leishmania serology (p = 0.060, Chi-square test, χ2 = 3.5, df = 1), although these associations did not reach statistical significance. Residence in a rural parish, regular contact with domestic animals and ownership of dogs were not significantly associated with a positive serology. In multivariate analysis, factors associated with a positive TOSV serological result were age ≥ 50 years old (aOR 1.70, 95% CI 1.04–2.77, p = 0.033), residing in the Alentejo region (aOR 3.05, 95% CI 1.85–5.02, p < 0.001) and having a positive or borderline Leishmania serology (OR 2.31, 95% CI 1.29–4.15, p = 0.005) (Table 4).

Table 3 Distribution of participants by serological result and by category for sociodemographic variables
Table 4 Potential risk factors for TOSV infection according to logistic regression models to estimate crude and adjusted odds ratio values

Discussion

This study represents the first nationwide TOSV human seroprevalence study in Portugal. National true seroprevalence was estimated at 2.6%, with regional values ranging from 0.0 to 14.8%. A comparison with previous regional studies shows overlapping positivity rates in the Península de Setúbal (5.1 vs. 5.3%; samples collected in 2019) [25] and Área Metropolitana do Porto (2.7 vs. 3.9%; published in 2011) [23] NUTS3 regions. Notably, the same serological technique was used in the first case, while ELISA was used in the second. The national and regional seroprevalence estimates of the present study are, however, considerably lower than suggested in regions of other Mediterranean countries (using the same serological technique), including in neighboring Spain (26.3% in the Granada province) [19] and especially in North Africa: Algeria (46.2%) [45] and Tunisia (41.0%) [46]. Factors explaining the lower seroprevalence in Portugal could be related to aspects of the presence, abundance and infection rate of the main vector of TOSV (Phlebotomus perniciosus) in the country. Although P. perniciosus seems to be widespread in Portugal [31], its abundance has not been well characterized. Data from national surveillance (2016–2023) show presence of P. perniciosus in all/most of the municipalities sampled in the Baixo Alentejo, Alto Alentejo and Douro [31], which were regions with higher estimated TOSV seroprevalence in the present study. Of note, no sand fly collection was systematically performed in regions such as Área Metropolitana do Porto, Cávado and Alto Tâmega e Barroso [31], nor have entomological data from these regions been reported previously in the literature, reflecting the insufficient knowledge on sand fly distribution in the northern part of Portugal. Additionally, TOSV has, to date, only been detected in sand flies collected in the Algarve region [in one of 45 pools distributed across the country [47]. Other sand fly species detected in Portugal (P. ariasi, P. papatasi, P. sergenti and Sergentomyia minuta) could also be competent for TOSV maintenance and transmission [48], but they seem to have a more localized distribution in the country [31]. Most of northern and coastal Portugal presents a Warm Summer Mediterranean (Csb) climate [49], where higher humidity and lower summer temperatures could be less favorable for sand flies [50], hence potentially contributing to a generally lower TOSV seroprevalence in these regions (such as Alto Minho, Aveiro and Leiria) compared to regions with a Hot Summer Mediterranean (Csa) climate. Lastly, differences in human behavior and exposure to sand fly bites could also play a role.

In this study, a likely intense exposure to TOSV is shown in areas where it had not previously been documented, namely in the interior of the Norte and in the Alentejo NUTS2 regions. Interestingly, several NUTS3 regions where a higher estimated seroprevalence was found are the same ones where a higher incidence of visceral leishmaniasis (VL) was documented in Portugal between 2010 and 2020, including the Alto Alentejo, Baixo Alentejo and Alto Tâmega e Barroso but not the Algarve [51]. In the Algarve, however, caution is required when interpreting the results, given the limited geographic coverage, as the lack of data from specific municipalities may have impacted the overall findings. In contrast, other regions where a higher estimated TOSV seroprevalence was calculated presented a lower VL incidence, such as the Oeste region. In this region, however, when analysis at municipality level is performed, the areas with positive TOSV donors overlap the areas where VL cases and Leishmania-positive donors were detected, namely Alenquer, Caldas da Rainha and Alcobaça (seropositivity in the first two exceeded 9% for both TOSV and Leishmania) [35]. Taken together, these findings support the co-circulation of TOSV and Leishmania in several regions of mainland Portugal. Additional studies could provide further insights into the environmental and sociodemographic factors associated with the differential exposure to these sand fly-borne pathogens in Portugal. Although information on the presence of different sand fly species at a nation-wide level has been increasing in recent years [31], data concerning relative abundance are still scarce and restricted to a few regions (e.g. the Algarve [52]).

The present study showed a significant association between detection at the individual level of TOSV and Leishmania antibodies in healthy individuals in an endemic region. This association was already reported [19, 34] and is likely explained by exposure to the common main vector in Portugal, P. perniciosus. Other factors associated with detection of TOSV antibodies in the present study have also been suggested in previous studies in blood donors, namely older age [19, 53], which could be related to the cumulative risk of exposure in endemic regions.

Male sex was not significantly associated with seropositivity in the present study; a similar finding was reported in a previous study in Corsica [54] but not in another study in Turkey [53]. This discrepancy may be attributed to variations in exposure factors and prevalence of high-risk behaviors by sex, which may differ across regions and contexts. Notably, TOSV symptomatic infections are consistently observed more frequently in males than in females [55], suggesting that other factors such as sex-related immune response and viral susceptibility may be relevant for symptomatic presentation.

Other factors found not to be significant in this study, in contrast with previous studies, included residing in rural areas or regular contact with domestic animals [53, 56]. Of note, the natural reservoir of TOSV still needs to be determined [57, 58].

In summary, these findings and the previous studies suggest that, in Portugal, raised clinical awareness regarding TOSV should be promoted, especially in the Alto Alentejo, Baixo Alentejo, Douro and Alto Tâmega e Barroso regions. TOSV should be considered in the differential diagnosis of suspected viral meningitis and encephalitis, especially from May to October, considering knowledge on the seasonal activity of phlebotomine sand flies in Portugal [59]. This clinical approach will also rely on the availability of molecular biology and serology techniques to detect TOSV in highly endemic areas.

Using serological techniques to determine exposure to TOSV has some limitations, including possible cross-reactivity with antigenically related phleboviruses. However, neutralization-based assays are considered the gold standard for the confirmation of Phlebovirus antibody specificity [60]. Seroneutralization is the most stringent and specific assay, in particular for Toscana virus [46].

Calculating sensitivity and specificity for microneutralization assays presents several challenges due to the absence of a definitive gold standard to determine true infection status, low prevalence rates, potential cross-reactivity and the selection of appropriate thresholds. In this study, we utilized sensitivity and specificity values derived from Zika virus data as these metrics were not available for the TOSV microneutralization technique. Since the Zika virus microneutralization assays were conducted using the same methodology and within the same laboratory unit, these values serve as a reasonable proxy. However, differences between the two viruses and their specific immune responses may introduce a slight bias in the results. Despite the many caveats for the use of serology for individual determination of previous TOSV infection status, the detection of antibodies can be relevant from a public health perspective, especially when comparing the findings between different regions and by crossing the results with distribution of human cases and evidence from TOSV in mammals and vectors following a One Health approach. This knowledge could be helpful to control human TOSV infections, highlighting regions where environmental interventions to reduce phlebotomine breeding sites and increased adherence to the use of arthropod repellent (from dusk to dawn) could be recommended. Future research should focus on understanding the specific ecological niches of TOSV in Portugal.

These findings cannot be transposed to the general Portuguese mainland population, since only healthy people aged 18–65 years were included and the profile of people who donate blood could be different from the age-matched general population in each region and between regions. In addition, the representativeness even of the blood donor population itself could have been affected by the difficulty in obtaining a truly probabilistic sample because of logistic constraints in some regions.

Conclusions

To our knowledge, this study provides the first nationwide estimate of TOSV seroprevalence in mainland Portugal, revealing a true seroprevalence of 2.6%, with significant regional variation. These findings suggest an increased exposure to TOSV in previously undocumented areas, particularly in parts of the Norte and Alentejo regions, and reinforce the association between TOSV and Leishmania infections. While the study's design focused on blood donors, the results underscore the importance of raising clinical awareness of TOSV, particularly in regions with higher seroprevalence and during the active sand fly season. Future research should explore the ecological factors contributing to the regional distribution of TOSV as well as potential public health interventions to reduce exposure to this emerging pathogen following a One Health approach.

Availability of data and materials

The datasets generated and analyzed during the current study are not publicly available due to confidentiality commitment with the participants, as stated in the consent declaration, but are available from the corresponding author on reasonable request.

References

  1. Zerbini FM, Siddell SG, Lefkowitz EJ, Mushegian AR, Adriaenssens EM, Alfenas-Zerbini P, et al. Changes to virus taxonomy and the ICTV statutes ratified by the International Committee on Taxonomy of Viruses (2023). Arch Virol. 2023;168:175.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Klimentov AS, Belova OA, Kholodilov IS, Butenko AM, Bespyatova LA, Bugmyrin SV, et al. Phlebovirus sequences detected in ticks collected in Russia: novel phleboviruses, distinguishing criteria and high tick specificity. Infect Genet Evol. 2020;85:104524.

    Article  CAS  PubMed  Google Scholar 

  3. Wright D, Kortekaas J, Bowden TA, Warimwe GM. Rift Valley fever: biology and epidemiology. J Gen Virol. 2019;1:1187–99.

    Article  Google Scholar 

  4. Calisher CH, Calzolari M. Taxonomy of phleboviruses, emphasizing those that are sandfly-borne. Viruses. 2021;13:918.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Braito A, Corbisiero R, Corradini S, Marchi B, Sancasciani N, Fiorentini C, et al. Evidence of Toscana virus infections without central nervous system involvement: a serological study. Eur J Epidemiol. 1997;13:761–4.

    Article  CAS  PubMed  Google Scholar 

  6. Konstantinou GN, Papa A, Antoniadis A. Sandfly-fever outbreak in Cyprus: are Phleboviruses still a health problem? Travel Med Infect Dis. 2007;5:239–42.

    Article  CAS  PubMed  Google Scholar 

  7. Ayhan N, Charrel RN. An update on Toscana virus distribution, genetics, medical and diagnostic aspects. Clin Microbiol Infect. 2020;26:1017–23.

    Article  CAS  PubMed  Google Scholar 

  8. Gori Savellini G, Gandolfo C, Cusi MG. Epidemiology of Toscana virus in South Tuscany over the years 2011–2019. J Clin Virol. 2020;128:104452.

    Article  CAS  PubMed  Google Scholar 

  9. Percivalle E, Cassaniti I, Calzolari M, Lelli D, Baldanti F. Thirteen years of phleboviruses circulation in Lombardy, a northern Italy region. Viruses. 2021;13:209.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Valassina M, Meacci F, Valensin PE, Cusi MG. Detection of neurotropic viruses circulating in Tuscany: the incisive role of Toscana virus. J Med Virol. 2000;60:86–90.

    Article  CAS  PubMed  Google Scholar 

  11. Sghaier W, Bahri O, Kedous E, Fazaa O, Rezig D, Touzi H, et al. Retrospective study of viral causes of central nervous system infections in Tunisia (2003–2009). Med Sante Trop. 2019;22:373–8.

    Google Scholar 

  12. Amaro F, Zé-Zé L, Luz MT, Alves MJ. Toscana virus: ten years of diagnostics in Portugal. Acta Med Port. 2021;34:677–81.

    Article  PubMed  Google Scholar 

  13. Ehrnst A, Peters CJ, Niklasson B, Svedmyr A, Holmgren B. Neurovirulent Toscana virus (a sandfly fever virus) in Swedish man after visit to Portugal. Lancet. 1985;325:1212–3.

    Article  Google Scholar 

  14. Schwarz TF, Jäger G, Gilch S, Pauli C, Eisenhut M, Nitschko H, et al. Travel-related vector-borne virus infections in Germany. In: Imported virus infections. Vienna: Springer Vienna; 1996. p. 57–65.

    Chapter  Google Scholar 

  15. Santos L, Simões J, Costa R, Martins S, Lecour H. Toscana virus meningitis in Portugal, 2002–2005. Eurosurveillance. 2007;12:3–4.

    Article  Google Scholar 

  16. Amaro F, Luz T, Parreira P, Marchi A, Ciufolini MG, Alves MJ. Serological evidence of Toscana virus infection in Portuguese patients. Epidemiol Infect. 2012;140:1147–50.

    Article  CAS  PubMed  Google Scholar 

  17. Dersch R, Sophocleous A, Cadar D, Emmerich P, Schmidt-Chanasit J, Rauer S. Toscana virus encephalitis in Southwest Germany: a retrospective study. BMC Neurol. 2021;21:495.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Sanbonmatsu-Gámez S, Pérez-Ruiz M, Collao X, Sánchez-Seco MP, Morillas-Márquez F, De La Rosa-Fraile M, et al. Toscana virus in Spain. Emerg Infect Dis. 2005;11:1701–7.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ortuño M, Muñoz C, Spitzová T, Sumova P, Iborra MA, Pérez-Cutillas P, et al. Exposure to Phlebotomus perniciosus sandfly vectors is positively associated with Toscana virus and Leishmania infantum infection in human blood donors in Murcia Region, southeast Spain. Transbound Emerg Dis. 2022;69:e1854–64.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Brisbarre N, Attoui H, Gallian P, di Bonito P, Giorgi C, Cantaloube JF, et al. Seroprevalence of Toscana virus in blood donors, France, 2007. Emerg Infect Dis. 2011;17:941–3.

    Article  PubMed  PubMed Central  Google Scholar 

  21. De Lamballerie X, Tolou H, Durand JP, Charrel RN. Prevalence of Toscana virus antibodies in volunteer blood donors and patients with central nervous system infections in southeastern France. Vector-Borne Zoonotic Dis. 2007;7:275–7.

    Article  PubMed  Google Scholar 

  22. Morini S, Calzolari M, Rossini G, Pascarelli N, Porcellini A, Randi V, et al. Detection of specific antibodies against Toscana virus among blood donors in northeastern Italy and correlation with sand fly abundance in 2014. Microorganisms. 2020;8:145.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Santos L, Cardoso MJ, Marinho AS, Guimarães T, Sarmento A. Seroprevalence survey of Toscana virus infection in Oporto region. Acta Med Port. 2011;24:379–82.

    PubMed  Google Scholar 

  24. Amaro F, Luz T, Parreira P, Ciufolini MG, Marchi A, Janeiro N, et al. Toscana virus in the Portuguese population: serosurvey and clinical cases. Acta Med Port. 2011;24:503–8.

    PubMed  Google Scholar 

  25. Maia C, Ayhan N, Cristóvão JM, Pereira A, Charrel R. Human seroprevalence of Toscana virus and Sicilian phlebovirus in the southwest of Portugal. Eur J Clin Microbiol Infect Dis. 2022;41:137–41.

    Article  CAS  PubMed  Google Scholar 

  26. Alwassouf S, Maia C, Ayhan N, Coimbra M, Cristovao JM, Richet H, et al. Neutralization-based seroprevalence of Toscana virus and sandfly fever Sicilian virus in dogs and cats from Portugal. J Gen Virol. 2016;97:2816–23.

    Article  CAS  PubMed  Google Scholar 

  27. Maia C, Alwassouf S, Cristóvão JM, Ayhan N, Pereira A, Charrel RN, et al. Serological association between Leishmania infantum and sand fly fever Sicilian (but not Toscana) virus in sheltered dogs from southern Portugal. Parasit Vectors. 2017;10:92.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Pereira A, Ayhan N, Cristóvão JM, Vilhena H, Martins Â, Cachola P, et al. Antibody response to Toscana virus and Sandfly Fever Sicilian virus in cats naturally exposed to phlebotomine sand fly bites in Portugal. Microorganisms. 2019;7:339.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Amaro F. Phlebovirus, Importância em Saúde Pública em Portugal. PhD thesis, Biology (Microbiology), Universidade de Lisboa, Faculdade de Ciências, 2010.

  30. Depaquit J, Grandadam M, Fouque F, Andry P, Peyrefitte C. Arthropod-borne viruses transmitted by phlebotomine sandflies in Europe: a review. Eurosurveillance. 2010. https://doiorg.publicaciones.saludcastillayleon.es/10.2807/ese.15.10.19507-en.

    Article  PubMed  Google Scholar 

  31. Centro de Estudos de Vetores e Doenças Infeciosas Doutor Francisco Cambournac. Relatório REVIVE 2023—Culicídeos, Ixodídeos e Flebótomos: Rede de Vigilância de Vetores. 2024.

  32. de Freitas MT, Maia C. Phlebotomus perniciosus. Trends Parasitol. 2024;40:649–50.

    Article  Google Scholar 

  33. Amaro F, Vilares A, Martins S, Reis T, Osório HC, Alves MJ, et al. Co-Circulation of Leishmania parasites and Phleboviruses in a population of sand flies collected in the South of Portugal. Trop Med Infect Dis. 2023;9:3.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bichaud L, Souris M, Mary C, Ninove L, Thirion L, Piarroux RP, et al. Epidemiologic relationship between Toscana virus infection and Leishmania infantum due to common exposure to Phlebotomus perniciosus sandfly vector. PLoS Negl Trop Dis. 2011;5:e1328.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Rocha R, Gonçalves L, Conceição C, Andrade P, Cristóvão JM, Condeço J, et al. Prevalence of asymptomatic Leishmania infection and knowledge, perceptions, and practices in blood donors in mainland Portugal. Parasit Vectors. 2023;16:357.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Instituto Português do Sangue e da Transplantação I. Relatório de Atividade Transfusional e Sistema Português de Hemovigilância 2022. Lisboa. 2023. https://www.hemovigilancia.net/files/RA_2022.pdf.

  37. Fundação Francisco Manuel dos Santos. O que são NUTS? PORDATA. https://www.pordata.pt/o+que+sao+nuts.

  38. INE. Resultados Provisórios. 2021. Resultados Provisórios—Censos 2021.

  39. ESCO. Classification of Occupations. https://esco.ec.europa.eu/en/classification/occupation_main.

  40. Programa de desenvolvimento rural 2014–2020. Freguesias Rurais PDR2020 (nova Divisão Administrativa freguesias 2013). https://www.gpp.pt/images/Estatisticas_e_analises/Estatisticas/associadasmedidasapoio/Territorios_Rurais.pdf.

  41. Nurtop E, Villarroel PMS, Pastorino B, Ninove L, Drexler JF, Roca Y, et al. Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies. Virol J. 2018;15:192.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Sargent E. Ausvet. 2018. Epitools Epidemiological Calculators. https://epitools.ausvet.com.au/.

  43. Greiner M, Gardner IA. Application of diagnostic tests in veterinary epidemiologic studies. Prev Vet Med. 2000. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S0167-5877(00)00116-1.

    Article  PubMed  Google Scholar 

  44. Fagerland MW, Hosmer DW. A generalized Hosmer-Lemeshow goodness-of-fit test for multinomial logistic regression models. Stata J. 2012;45:43–59.

    Google Scholar 

  45. Alkan C, Allal-Ikhlef AB, Alwassouf S, Baklouti A, Piorkowski G, de Lamballerie X, et al. Virus isolation, genetic characterization and seroprevalence of Toscana virus in Algeria. Clin Microbiol Infect. 2015;21:1040.e1-1040.e9.

    Article  CAS  PubMed  Google Scholar 

  46. Sakhria S, Bichaud L, Mensi M, Salez N, Dachraoui K, Thirion L, et al. Co-circulation of Toscana virus and Punique virus in Northern Tunisia: a microneutralisation-based seroprevalence study. PLoS Negl Trop Dis. 2013;7:e2429.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Amaro F, Zé-Zé L, Osório HC, Soares P, Silva M, Freitas IC, et al. Toscana virus in wild-caught sand flies in Portugal, findings from the National Vector Surveillance Network, 2023. Pathogens. 2024;13:905.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Ayhan N, Prudhomme J, Laroche L, Bañuls AL, Charrel RN. Broader geographical distribution of Toscana virus in the Mediterranean region suggests the existence of larger varieties of sand fly vectors. Microorganisms. 2020;8:114.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Cunha S, Silva Á, Herráez C, Pires V, Chazarra A, Mestre A, et al. Atlas Climático Ibérico—Iberian Climate Atlas. 2011.

  50. Risueño J, Muñoz C, Pérez-Cutillas P, Goyena E, Gonzálvez M, Ortuño M, et al. Understanding Phlebotomus perniciosus abundance in south-east Spain: assessing the role of environmental and anthropic factors. Parasit Vectors. 2017;10:189.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Rocha R, Conceição C, Gonçalves L, Carvalho AC, Maia A, Martins A, et al. Epidemiological and clinical trends of visceral leishmaniasis in Portugal: retrospective analysis of cases diagnosed in public hospitals between 2010 and 2020. Infect Dis Poverty. 2024;13:41.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Maia C, Afonso MO, Neto L, Dionísio L, Campino L. Molecular detection of Leishmania infantum in naturally infected Phlebotomus perniciosus from Algarve region. Portugal J Vector Borne Dis. 2009;46:268–72.

    CAS  PubMed  Google Scholar 

  53. Ergunay K, Aydogan S, Ilhami Ozcebe O, Cilek EE, Hacioglu S, Karakaya J, et al. Toscana Virus (TOSV) exposure is confirmed in blood donors from Central, North and South/Southeast Anatolia. Turkey Zoonoses Public Health. 2012;59:148–54.

    Article  CAS  PubMed  Google Scholar 

  54. Masse S, Ayhan N, Capai L, Bosseur F, de Lamballerie X, Charrel R, et al. Circulation of Toscana virus in a sample population of Corsica, France. Viruses. 2019;11:817.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Ayhan N, Eldin C, Charrel R. Toscana virus infection clinical characterization. medRxiv. 2024;14:294.

    Google Scholar 

  56. Ayari R, Chaouch H, Findlay-Wilson S, Hachfi W, Ben Lasfar N, Bellazreg F, et al. Seroprevalence and risk factors associated with Phleboviruses and Crimean-congo Hemorrhagic fever virus among blood donors in central Tunisia. Pathogens. 2024;13:348.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Muñoz C, Ayhan N, Ortuño M, Ortiz J, Gould EA, Maia C, et al. Experimental infection of dogs with Toscana virus and sandfly fever Sicilian virus to determine their potential as possible vertebrate hosts. Microorganisms. 2020;8:596.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Dachraoui K, Chelbi I, Labidi I, Ben Osman R, Sayadi A, Ben Said M, et al. The role of the Leishmania infantum infected dogs as a potential reservoir host for Toscana virus in a zoonotic visceral leishmaniasis focus of Northern Tunisia. Viruses. 2023;15:1012.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Zé-Zé L, Amaro F, Osório HC, Giovanetti M, Lourenço J, Alves MJ. Molecular identification and ecology of Portuguese wild-caught phlebotomine sandfly specimens. Zoonotic Dis. 2022;2:19–31.

    Article  Google Scholar 

  60. Ergünay K, Litzba N, Lo MM, Aydoğan S, Saygan MB, Us D, et al. Performance of various commercial assays for the detection of Toscana virus antibodies. Vector-Borne Zoonotic Dis. 2011;11:781–7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors acknowledge all the blood donors who agreed to participate in this study for contributing their answers to the questionnaire and their blood samples. The authors also acknowledge all the professionals of the following institutions who contributed to the organizing the physical equipment, presentation of the study to potential participants, obtaining informed consent, separation and storage of samples and implementing questionnaires: Instituto Português do Sangue e da Transplantação; Centro Hospitalar Universitário do Algarve; Hospital do Espírito Santo de Évora; Unidade Local de Sáude do Norte Alentejano; Unidade Local de Saúde do Baixo Alentejo and Unidade Local de Saúde do Litoral Alentejano.

Funding

The authors acknowledge FCT for funding through contracts with GHTM (UID/Multi/04413/2020) and LA-REAL (LA/P/0117/2020). The work of NA, RC and CM was supported by the CLIMOS consortium and is cataloged by the CLIMOS Scientific Committee as CLIMOS number 18 (http://www.climos-project.eu). The CLIMOS consortium is co-funded by the European Commission grant 101057690 and UKRI grants 10038150 and 10039289. The contents of this publication are the sole responsibility of the author and do not necessarily reflect the views of the European Commission, the Health and Digital Executive Agency or UKRI. Neither the European Union nor the granting authority nor UKRI can be held responsible. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. For the purposes of Open Access, the authors have applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. The six Horizon Europe projects, BlueAdapt, CATALYSE, CLIMOS, HIGH Horizons, IDAlert and TRIGGER, form the Climate Change and Health Cluster. This work was also supported in part by the DURABLE project (#101102733, Call EU4H-2021-PJ4) of the EU4H program by the HADEA agency of the European Commission. EK is a recipient of the Study Abroad Postgraduate Education Scholarship (MEB 1416) awarded by the Ministry of National Education of the Republic of Turkey.

Author information

Authors and Affiliations

Authors

Contributions

RR: Conceptualization, Methodology, Validation, Investigation, Formal analysis, Writing—Original Draft, Visualization. EK: Methodology, Investigation. NA, RC: Conceptualization, Methodology, Validation, Investigation, Writing—Review & Editing. CM: Conceptualization, Methodology, Validation, Writing—Review & Editing, Supervision.

Corresponding author

Correspondence to Carla Maia.

Ethics declarations

Ethics approval and consent to participate

This study received an approval of the Ethics Committee of the Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (reference 17.22). All participants signed an informed consent form allowing for sample and data collection for this study.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rocha, R., Kurum, E., Ayhan, N. et al. Seroprevalence of Toscana virus in blood donors in mainland Portugal. Parasites Vectors 18, 82 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13071-025-06726-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13071-025-06726-x

Keywords